본문 바로가기
주메뉴 바로가기
Immunology
About Us
Pipeline
Inflammasome
Nanobody
INVESTORS
News
Careers
ENG
KOR
ENG
Shaperon
About Us
About Shaperon
Our History
Value Proposition
Partners & Investors
Contact
Pipeline
Line Up
NuGel®
NuCerin®
NuSepin®
Oral Inflammasome Inhibitors
Papiliximab®
Saviximab®
Inflammasome
Nanobody
Investors
Notice
IR Presentation
IR News
Public Disclosure
News
Press Release
Media Room
Corporate News
Careers
Shaperon Core Values
Process
Current Job Opportunities
About Us
About Shaperon
Our History
Value Proposition
Partners & Investors
Contact
Pipeline
Line Up
NuGel®
NuCerin®
NuSepin®
Oral Inflammasome Inhibitors
Papiliximab®
Saviximab®
Inflammasome
Nanobody
Investors
Notice
IR Presentation
IR News
Public Disclosure
News
Press Release
Media Room
Corporate News
Careers
Shaperon Core Values
Process
Current Job Opportunities
investors
HOME
investors
Public Disclosure
investors
Notice
IR Presentation
IR News
Public Disclosure
Public Disclosure